other

Vesugen

FDA: not-FDA-approved

Vesugen is a vascular bioregulator peptide that supports endothelial repair, blood vessel elasticity, and microcirculation. It is used for age-related vascular stiffening, atherosclerosis, and hypertension in Russian bioregulator protocols. Bioregulator peptide targeting vascular endothelium. Supports endothelial repair and blood vessel elasticity. Improves microcirculation and reduces age-related vascular stiffening. Operates epigenetically to maintain vascular gene expression and cellular homeostasis. - Endothelial repair and vascular health - Blood vessel elasticity improvement - Microcirculation enhancement - Age-related vascular stiffening reduction - Atherosclerosis and hypertension support - Standard: 10-20 mg per cycle, SubQ or oral - Cycle: 10-20 days, repeated 2-4x/year - Route: Oral,

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight
Half-life
CAS number
Route
02

Sourcing

Current prices

Updated today

20mg

Stocks this compound Third-party tested Public COAs Positive rep

Save 15% with code VIALBASE at checkout

Stocks this compound Third-party tested Public COAs Positive rep
Stocks this compound Third-party tested Public COAs

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • Lipid Panel
DURING CYCLE
  • Lipid Panel
POST-CYCLE
  • CMP
  • Lipid Panel
Safety & Regulatory Status
FDA STATUS not-FDA-approved

Regulatory status for Vesugen may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.